The 340B Drug Pricing Program

The federal 340B program requires drug makers to sell their products to some hospitals at a discount. Hospitals and contract pharmacies can then resell them and pocket the difference. It’s a case of the government picking winners (hospitals) and losers (drug manufacturers) among private market participants. Hospitals argue that they need the money to help patients. That is, they use the extra revenue from the program to cut costs or provide free care for those in need. But Jarrett Skorup of the

24K views · 124 reactions | America’s seniors rely on the 340B drug discount program to combat skyrocketing drug costs. President Trump - America’s seniors are depending on you - don’t harm the #340B Drug Discount Program. https://bit.ly/2z06tmW | 340B Matters | Facebook

Effective Administration of the 340B Drug Pricing Program | The U.S. Senate Committee on Health, Education, Labor & Pensions

Oversight and Investigations Subcommittee Hearing: “Oversight of 340B Drug Pricing Program”

Taxpayers are footing the bill for the 340B Drug Pricing Program. Hospitals, contract pharmacies, and special interest sharks are profiting. They’re taking advantage of 340B discounts meant for patients, and it’s costing taxpayers. We can fix the mess if Congress reforms the program. https://www.cagw.org/340B #Fix340B | Citizens Against Government Waste

Ben’s story is just one example of how the #340B drug pricing program has helped Michigan patients access critical, community-based care close to home. To learn more or contact your lawmakers to urge they #Protect340B, visit: https://bit.ly/3MTH8l8 | Michigan Health & Hospital Association | Facebook